The study aims to investigate surface markers on dendritic cells (DCs) in patients with systemic lupus erythematosus (SLE) and their role in the disease's development.
By separating peripheral blood mononuclear cells (PBMCs) and stimulating DCs with specific cytokines, researchers analyzed various surface markers and cytokine levels through flow cytometry and ELISA.
Findings show that certain surface markers were significantly higher in SLE patients compared to normal subjects, suggesting that DCs may contribute to SLE pathogenesis through enhanced antigen presentation and IL-12 secretion.